May 5, 2020 / 1:22 PM / a month ago

BRIEF-FDA Provides Emergency Use Authorization To Perkinelmer For Serological Test To Identify Covid-19 Antibodies

May 5 (Reuters) - PerkinElmer Inc:

* FDA PROVIDES EMERGENCY USE AUTHORIZATION TO PERKINELMER FOR SEROLOGICAL TEST TO IDENTIFY COVID-19 ANTIBODIES

* PERKINELMER INC - EUROIMMUN HAS CAPACITY TO MANUFACTURE MILLIONS OF ASSAYS PER MONTH.

* PERKINELMER INC - SINCE MARCH, EUROIMMUN HAS ALREADY STARTED SHIPPING ITS ANTI-SARS-COV-2 ELISA

* PERKINELMER INC - EUROIMMUN INTENDS TO FURTHER BUILD PRODUCTION CAPACITY TO MEET HEIGHTENED DEMAND. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below